ConductScience.org, home

Paper268229

Prolonged remission maintenance in acute myeloid leukaemia.

Spiers AS and 5 others. Br Med J, 1977. Cited by 37 papers, by iCite.

Cite this record

ConductScience Library. Prolonged remission maintenance in acute myeloid leukaemia. Papers, record 268229. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/268229

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Prolonged remission maintenance in acute myeloid leukaemia.
PubMed
Journal
Br Med J
PubMed
Year
1977
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
37
iCite
Relative citation ratio, by iCite
1.91
iCite
Revised in PubMed
2019-05-01
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Spiers ASA S
2Goldman JMJ M
3Catovsky DD
4Costello CC
5Galton DAD A
6Pitcher CSC S

Source PubMed

Download CSV of authors

Topics21

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
Leukemia, Myeloid, AcuteMajor topic
Adolescent
Adult
Aged
Child
Child, Preschool
Cyclophosphamide
Cytarabine
Daunorubicin
Drug Therapy, Combination
Female
Humans
Male
Mercaptopurine
Methotrexate
Middle Aged
Prednisolone
Remission, Spontaneous
Thioguanine
Vincristine

Source PubMed

Download CSV of topics

References15

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1322689Immunotherapy for acute myelogenous leukaemia: a controlled clinical study 2 1/2 years after entry of the last patient.Br J Cancer1977https://conductscience.org/library/papers/322689PubMed
25100389Drug dosage and remission duration in childhood lymphocytic leukemia.Cancer1971https://conductscience.org/library/papers/5100389PubMed
3984987Adult acute leukemia. The Rochester (NY) Experience.Arch Intern Med1976https://conductscience.org/library/papers/984987PubMed
44140327Chemoimmunotherapy of adult acute leukaemia. Prolongation of remission in myeloblastic leukaemia with B.C.G.Lancet1974https://conductscience.org/library/papers/4140327PubMed
54179349Daunorubicin in the treatment of acute myelocytic leukaemia.Lancet1969https://conductscience.org/library/papers/4179349PubMed
652000Quality and quantity of survival in acute myeloid leukaemia.Lancet1975https://conductscience.org/library/papers/52000PubMed
74553226Treatment of the acute leukemias.Semin Hematol1972https://conductscience.org/library/papers/4553226PubMed
84509106Acute myelocytic leukemia in adults.Cancer1972https://conductscience.org/library/papers/4509106PubMed
94513355Management of adult acute myelogenous leukaemia.Br Med J1973https://conductscience.org/library/papers/4513355PubMed
104921703Combination chemotherapy using L-asparaginase, daunorubicin, and cytosine arabinoside in adults with acute myelogenous leukaemia.Br Med J1970https://conductscience.org/library/papers/4921703PubMed
115279904Five-year follow-up of "total therapy" of childhood lymphocytic leukemia.JAMA1971https://conductscience.org/library/papers/5279904PubMed
125286084Factors effecting remission and survival in adult acute nonlymphocytic leukemia (ANLL).Medicine (Baltimore)1970https://conductscience.org/library/papers/5286084PubMed
135284835Cytosine arabinoside in acute granulocytic leukemia.Clin Pharmacol Ther1971https://conductscience.org/library/papers/5284835PubMed
141057450Treatment of acute leukemia in adults.Cancer1975https://conductscience.org/library/papers/1057450PubMed
15793554Developmental therapy in adult acute leukemia.Arch Intern Med1976https://conductscience.org/library/papers/793554PubMed

Download CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 37 citations.

PMIDTitleJournalYearIn PapersSource
27517413Acute myeloid leukaemia-A review of sixty-seven cases.Ir J Med Sci1979https://conductscience.org/library/papers/27517413PubMed
7347042Remission-induction regimens in acute nonlymphocytic leukemia.West J Med1980https://conductscience.org/library/papers/7347042PubMed
552411Cancer chemotherapy.J R Soc Med1979https://conductscience.org/library/papers/552411PubMed
365212Chemotherapy of acute myeloid leukaemia in adults: Medical Research Council.Br J Cancer1979https://conductscience.org/library/papers/365212PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/268229

GET https://conductscience.org/api/papers/v1/268229/authors